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Abstract
Background: High blood pressure (BP) is a leading contributor to cardiovascular mortality globally. There is scarcity
of information on effective health systems interventions to lower BP and reduce cardiovascular risk in Southeast
Asian countries. We conducted a pilot exploratory trial on 100 adults aged 40 years or older with uncontrolled
hypertension to optimize the design for a structured multi-component intervention in primary care clinics for
management of hypertension.
Methods: Two clinics were involved, each enrolling 50 participants, with one as the intervention clinic and the
other as the control (usual care). The intervention comprised the following four components: 1) an algorithm-driven
intervention using a fixed-dose combination (FDC) antihypertensive treatment and lipid lowering medication for high
risk individuals, 2) subsidized FDC antihypertensive medication; 3) motivational conversation (MC) for high risk
individuals; and 4) telephone follow-ups of all individuals. The process outcomes were intervention fidelity
measures. The outcomes of change in parameters of interest were healthy lifestyle index (composite score of
body mass index, physical activity, dietary habit, dietary quality and smoking), adherence to antihypertensive
medications, and systolic and diastolic BP from baseline to follow-up at 3 months.
Results: Greater than 90 % fidelity was achieved for 3 of the 4 intervention components. Although not designed for
conclusive results, the healthy lifestyle score increased by 0.16 (±0.68) with the intervention and decreased by 0.
18 (±0.75) with usual care (p = 0.02). Adherence to anti-hypertensive medications at follow-up was 95.3 % in the
intervention group compared to 83.8 % for usual care (p = 0.01). Systolic and diastolic BP decreased in both
intervention and control groups, although statistical significance between groups was not achieved. Hypertensive
individuals rated all intervention components ‘highly favorable’ on a Likert scale.
Conclusions: Our findings indicate that the proposed, structured multi-component approach for management of
hypertension is feasible for implementation in primary care clinics in Singapore, with some changes to the protocol.
The observed improvement in the healthy lifestyle index and adherence to anti-hypertensive medications is promising.
A large scale, adequately powered trial would be informative to assess intervention effectiveness on BP and
cardiovascular risk reduction.
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Background
Hypertension is the leading attributable risk factor for
mortality in the Global Burden of Disease 2010. Over 1
billion people in the world have uncontrolled blood
pressure (BP), and this number is expected to increase
to 1.5 billion by 2030 [1].
The implications of uncontrolled BP are even greater in
Asian populations for whom the relationship between BP
and stroke is steep [2]. Successive reports from the Na-
tional Health Surveys (NHS) have highlighted the consist-
ently elevated burden of hypertension in Singapore. In the
2010 NHS, one in four adults aged 30 years or older
suffered from hypertension [3]. About 50 % of individ-
uals with hypertension had uncontrolled BP, and only
half of these individuals were on antihypertensive
treatment. Immediate health systems interventions are
therefore needed.
A systematic review of 72 randomized controlled trials
evaluating several health systems strategies to control BP
(self-monitoring, organization of care, educational initia-
tives directed at patients or physicians, nurse- or
pharmacist-led care, automated appointment reminders)
suggest benefit of organized or structured care compris-
ing multiple strategies, compared to single interventions
[4]. More recently, secondary analysis of pre- and post-
implementation of structured hypertension manage-
ment programs in the insured US population, with
components including fixed dose combination (FDC)
antihypertensive agents and medical assistant visits for
measurement of BP, has demonstrated beneficial impact
on BP control [5]. However, there is a dearth of empir-
ical trial evidence on strategies to enhance effectiveness
of comprehensive care for hypertension and other
chronic conditions in Singapore and countries with
similar healthcare infrastructure [6].
Although the vast majority of patients seek care from
private GPs, the data from the National Health Survey
Singapore 2010 indicated that about 45 % of individuals
with chronic conditions (hypertension or diabetes) visit
the government subsidized polyclinics. We therefore
conducted a pilot exploratory trial on 100 adults with
uncontrolled hypertension to optimize the design of a
structured multi-component interventional study in the
primary care clinics for management of hypertension.
The intervention consisted of the following four compo-
nents: 1) an algorithm-driven intervention using fixed-
dose combination (FDC) antihypertensive treatment
and lipid lowering medication for high risk individuals;
2) subsidized FDC antihypertensive medication; 3) mo-
tivational conversation (MC) for high risk individuals;
and 4) telephone follow-ups of all individuals with
hypertension by a team of physician-supervised nurse
practitioners and nurses. The comparator was usual
care in the polyclinics.
The overall aim was to assess feasibility of interven-
tion implementation in polyclinics with regards to fidel-
ity of the main interventional components by using the
polyclinic workforce and infrastructure to inform the
design and scalability of a future full scale cluster-
randomized controlled trial (cRCT). We also evaluated
the impact of the proposed strategies on change in
healthy life style, adherence to antihypertensive medica-
tions, and BP levels. In addition, using linear mixed




The feasibility study was a non-randomized, parallel arm,
cluster allocation of two polyclinics: one clinic to the inter-
vention group and one clinic to the usual care (control)
group. The trial protocol was approved by SingHealth IRB,
and registered at clintrial.gov NCT02330224.
Inclusion criteria
All individuals aged 40 years or older who were
Singapore citizens or Permanent Residents visiting the
recruiting polyclinic at least twice during the last one
year with a diagnosis of hypertension and uncontrolled
BP (systolic BP 140 mmHg and above, or diastolic BP
90 mmHg and above).
Exclusion criteria
Active systemic illness including fever, hospitalization
during prior 4 months, clinically unstable heart failure,
advanced kidney disease (estimated CKD-EPI glomerular
filtration rate (GFR) < 40 ml/min/1.73 m2 or nephrotic
range proteinuria (i.e., 3 g/day or more)), known ad-
vanced liver disease, pregnancy, or any other major
debilitating disease or mental illness that precluded val-
idity of informed consent [7].
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Screening and recruitment
The polyclinics have a system in place where all individ-
uals with hypertension or diabetes receive a “panel” of
fasting blood and urine tests at subsidized cost at the
time of initial diagnosis and then annually.
Individuals visiting a study polyclinic for their annual
panel of laboratory tests marked “hypertension panel”
and aged 40 years or older were identified by the labora-
tory technicians and referred to the dedicated study
research coordinator—present at the laboratory—who
invited them to be screened for eligibility in the study.
All individuals presenting at polyclinics undergo com-
puterized cardiovascular diseases (CVD) risk scoring
(using Singapore version of CVD score for men and
women) at triage. BP was measured thrice, in the sit-
ting position with arm rested, using a digital device
(OMRON HEM-7300). The average of the last two of
three BP readings, obtained three minutes apart, was
used to confirm eligibility. Those with BP ≥ 140/
90 mmHg were considered to have uncontrolled hyper-
tension. Written informed consent was then obtained
by the research coordinator. A total of 100 participants
were recruited: 50 in each clinic.
The research coordinator administered a brief study
questionnaire for information on socio-demographics.
In addition, EQ-5D-5 L was administered to ascertain
health related quality of life. Anthropometric measure-
ments obtained were waist, height and weight. All
participants were offered light refreshments after com-
pletion of the study questionnaire and received a S$5
voucher as reimbursement in both polyclinics.
Intervention
1) Training Physicians in Treatment algorithm:
All physicians from the intervention polyclinic
were invited for training in the treatment algorithm
(Fig. 1). Intensive training sessions (3 h sessions over
2 days) were scheduled during regular continued
medical education (CME) hours for the convenience
of providers. After CVD risk assessment at triage
and measurement of BP by research coordinators,
participants were triaged to physicians for evaluation,
including prescription of antihypertensive medications
per treatment algorithm.
All participants with a CVD score indicating risk
of acute coronary heart disease of 20 % or greater
over 10 years, or with diabetes, or pre-existing
CVD were categorized as “high risk”. All other
participants were categorized as “low/medium risk”.
In all “high risk” participants, the angiotensin
receptor blocker (ARB), losartan, plus hydrochloro-
thiazide (HCTZ) diuretic was initiated as a single
pill fixed-dose combination (FDC) at half-standard
dose of each. Participants were titrated to full dose
if BP remained uncontrolled at a subsequent visit in
Fig. 1 Treatment algorithm
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4–6 weeks and initiated on lipid lowering therapy
with statins [8, 9]. This combination regimen has
been shown to be effective and safe in lowering
BP and preventing CVD in some trials [10–13].
The first-line antihypertensive medication for
participants at “low/medium risk” was calcium
channel blockers (CCB). The next agents would
be ACE inhibitors (ACEI) (preferably in those less
than 55 years) or thiazide-type diuretics (preferably
in those aged 55 years and older) initiated at full
standard dose and up-titrated as necessary [14].
However if BP was greater than 20/10 mmHg above
target at the initial visit, FDC therapy was initiated
except in the very elderly (aged 80 years or older)
in whom therapy with single agent was preferred
[15]. The target BP for individuals aged < 80 years
was < 140/90 mmHg, and < 150/90 mmHg for the
very elderly.
2) Subsidy to FDC Antihypertensive Medication:
The ARB/HCTZ diuretic FDC antihypertensive
medication was subsidized at 50 % of the standard
price at the intervention clinic. This subsidy was in
line with the existing practice at the government
sector hospitals in Singapore.
3) Training Nurses in Motivational Conversation:
A special curriculum for hypertension management
was prepared by the psychologists in
consultation with the physicians using relevant
case studies. Nurses and nurse practitioners in
the intervention clinic were trained for 2 days
(4 h session each) by the psychologist. The
counseling approach of MC to high risk
participants focused on principles of empathy
and aimed to strengthen personal motivation
and commitment to setting priorities for self-care
and medication adherence by eliciting and exploring
a person’s own reasons for change within an
environment of acceptance and compassion [16].
The duration of a session was recorded.
4) Structured Follow-up over Telephone:
All participants in the intervention clinic were
followed via telephone by the nurses trained in MC,
and received advice for adherence to treatment
by the nurse at week 4 and week 8 from the time
of recruitment. Information on adverse events
was also obtained and an action plan (discontinue
the suspected drug and arrange visit to clinic,
as appropriate) was communicated accordingly.
A standardized checklist with questions on
lifestyle modification and adherence to medications
was used to communicate the key messages
(Additional file 1). The average duration of a call
was recorded. The nurses discussed the checklists
with the physicians on weekly basis.
Usual care
The health providers in the polyclinic allocated to usual
care continued their existing practices. Also, the partici-
pants continued to pay for the services (i.e., physician or
nurse consultation, any diagnostics or medications) as
per their existing model of reimbursement.
Outcomes assessment
All participants were assessed at the clinic by dedicated
research coordinators at baseline and after three months
when BP was measured. The research coordinators also
called the participants by telephone for outcomes assess-
ment at 6 weeks after baseline and administered a follow-
up questionnaire on lifestyle (tobacco use), information on
BP self-monitoring, self-care, medication use (traditional
medicines) and medication adherence. At the final clinic
visit in the intervention group a research coordinator also
administered a semi-qualitative questionnaire along with
the follow-up questionnaire to all the participants. This
semi-qualitative questionnaire captured participants’ per-
spectives about the telephone follow-up calls and also
about the MC and subsidized FDC to those identified as
high CVD risk individuals. At the end of the study nurses
were interviewed to understand their perspectives on the
telephone follow-up calls and MC.
Drug information was extracted through pharmacy
dispensing records. During the monthly outcomes as-
sessments, information on these costs and any hospitali-
zations were also obtained. Reasons for hospitalizations
and costs incurred were recorded.
Each participant was given a S$20 grocery store vou-
cher per study visit as remuneration for participation in
the study.
Statistical analysis
The main process outcome of interest was intervention
fidelity defined as the proportion of a) the planned
orientation sessions delivered to physicians and nurses,
b) the prescription of FDC to eligible participants, c) the
delivery of MC to eligible participants, and d) the tele-
phone follow-ups.
The other key outcomes were differences between treat-
ment groups in change from baseline to final follow-up at
three months for the following:
1) Change in healthy lifestyle index (HLI) [17–20]
(Additional file 2)
2) Adherence to antihypertensive medications.
3) Change in systolic BP (SBP)
4) Change in diastolic BP (DBP)
5) Quality of life assessed via EQ-5D-5 L
The Healthy lifestyle index (HLI) is a composite score of
five variables, namely BMI, self-reported physical activity,
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dietary habits, dietary quality and smoking (Additional file
2). Score of 0 was considered as poor health while score of
5 was considered to be excellent health [18–20]. Medica-
tion adherence was computed using the proportion of
days covered (PDC), where length of follow-up was the
denominator and total number of days’ supply of medi-
cation dispensed was the numerator [21]. In addition,
self-reported adherence was also analyzed via Morisky
Medication Adherence Scale (MMAS-8) on a continu-
ous scale.
All enrolled participants were included in the analyses
on an intention-to-treat basis. Throughout, p-values < 0.05
were considered statistically significant. We compared
baseline characteristics between the two groups using a
2-sample t-test for continuous variables and Fisher’s
exact test for categorical variables. The last observation
carried forward (LOCF) method was used to impute
missing values.
Change from baseline in systolic BP was compared be-
tween the two groups using a general linear mixed
model with difference in SBP as the dependent variable
and independent variables clinic, baseline SBP, age, gen-
der, diabetes and house ownership. The EQ-5D-5 L
index score was calculated using the Japan value sets.
The weekly per individual cost of antihypertensive
medications in both groups was computed. We also per-
formed a limited tabulation of direct intervention cost of
delivering motivational conversation by the nurses, tele-
phone follow-ups, and FDC subsidy at the hypertensive
individual level.




A detailed description of recruitment (CONSORT flow
diagram) is shown in Fig. 2. The week 6 telephone call
follow-up rate by research coordinators was 100 % in
the intervention clinic compared to 96 % for usual care.
The response rate for the final clinic visit was 97.8 % in
the intervention clinic compared to 100 % for usual care
in targeted participants.
Baseline characteristics
As shown in Table 1, participants in the intervention
group were older (p < 0.001), less educated (p < 0.001),
greater Chinese ethnicity (p < 0.001), and less likely to
own a home (p = 0.04) than those in the usual care
group. The mean age (±SD) in the intervention group
was 66 ± 10.3 while that in usual care group was 58.48 ±
8.3 (p < 0.001).
Intervention fidelity
Figure 3 shows intervention fidelity achieved.
Training sessions
All (100 %) of the planned orientation sessions on treat-
ment algorithm and MC, including telephone follow-ups
were delivered to the participating physicians and
nurses. The duration of each physician orientation ses-
sion was 2 h and each MC session 4 h. Attendance at
sessions was over 90 % of expected participants.
Prescription of FDC to eligible participants
Amongst those identified as high CVD risk individuals,
47.4 % received a fixed dose combination of antihyper-
tensive medication at 50 % subsidized cost.
Delivery of MC to eligible participants
One hundred percent of eligible participants received MC.
The average duration of the MC was around 40 min.
Delivery of telephone follow-ups
The response rate for week 4 and week 8 telephone
follow-up calls by nurses was 95.7 %. The average dur-
ation of each call was 14 min.
Outcomes
During 3-month follow-up, the healthy lifestyle index
increased by an average of 0.16 (±0.68) units in the
intervention group and decreased by 0.18 (±0.75) in the
usual care group, with the difference statistically signifi-
cant (p = 0.02). The adherence to antihypertensive med-
ications was significantly better in the intervention
compared to usual care group, both for any antihyper-
tensive medication (p < 0.01) as well as all hypertensive
medications (p = 0.03) (Table 2).
Mean systolic and diastolic BP declined significantly
in both intervention and usual care groups, however,
the difference in these changes was not statistically
significant. The unadjusted intra-cluster correlations
(ICC) for differences in SBP and DBP were 0.02 and
0.33, respectively.
The adjusted quality of life score tended to improve in
the intervention group (mean, 0.01; range, −0.04 to 0.06)
and decline in the usual care group (mean, −0.02; range,
−0.07 to 0.03) (Table 3). The difference in change be-
tween groups was not statistically significant (p = 0.19).
The nurses who conducted the telephone based
follow-ups gave positive feedback in a group session but
suggested increasing the interval between the follow-up
calls. 86 % of participants were “happy or very happy”
with the telephone based follow-up, and 89 % of those
receiving MC responded similarly (Table 4).
The weekly cost of antihypertensive medications in-
curred by the hypertensive individuals in the interven-
tion and control groups was S$1.80 and S$1.70,
respectively (Table 5).
Jafar et al. BMC Health Services Research  (2016) 16:229 Page 5 of 12
The cost of face to face MC was S$12.1 per high risk
individual per session (average duration 40 min),
monthly telephone follow up call was S$4.5 per individ-
ual per call (average duration 14 min), and FDC antihy-
pertensive medication subsidy was S$ 1.4 per high risk
individual per week (Table 6).
Discussion
Our study on 100 participants with uncontrolled hyper-
tension in 2 polyclinics in Singapore demonstrated
feasibility of implementing a structured multicompo-
nent intervention consisting of 1) an algorithm-driven
antihypertensive regimen incorporating a fixed dose
combination (FDC) antihypertensive and lipid lowering
treatment for high risk individuals; 2) subsidy on FDC
antihypertensive medications; 3) motivational conversa-
tion (MC) for high risk individuals; and 4) telephone
follow-ups of all individuals with hypertension with
high intervention (> 90 % for 3 of 4 process outcomes).
Although not designed to yield conclusive results, the
Fig. 2 CONSORT flow diagram
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intervention increased the healthy lifestyle score by an
average (SD) of 0.16 (±0.68) at the intervention group
with a decrease of 0.18 (±0.75) for usual care (p = 0.02)
over 3 months. The adherence to anti-hypertensive
medications at follow-up was 95.3 % in the intervention
group compared to 83.8 % in usual care (p = 0.01). Sys-
tolic and diastolic BP decreased in both intervention
and control groups, however the difference was not sta-
tistically significant. Participants rated the intervention
components (MC, telephone follow-ups, subsidy on
FDC) ‘highly favorable’ on a Likert scale. A large scale,
adequately powered cluster RCT of the proposed inter-
vention with some additional measures to enhance
physician prescription of FDC antihypertensive medica-
tions to eligible participants would be informative re-
garding the effectiveness and cost-effectiveness of the
packaged approach for reduction of BP and cardiovas-
cular risk in this population.
The conduct of developmental and exploratory re-
search is important prior to undertaking full-scale trials
Table 1 Baseline characteristics of participants by study groups
Characteristic Intervention No Intervention p-valuea
Total (n = 100) (n = 50) (n = 50)
Mean age, y (SD) 66 (10.3) 58.48 (8.3) <0.001*
Median age, y (IQR) 68 (60.3, 72.0) 59 (52.3, 64.0) <0.001*
Age (y), n (%) <0.01*
40-59 12 (24.0) 26 (52.0)
60-74 28 (56.0) 22 (44.0)
≥ 75 10 (20.0) 2 (4.0)
Men, n (%) 22 (44.0) 25 (50.0) 0.69
Ethnicity, n (%) <0.001*
Chinese 47 (94.0) 23 (46.0)
Malay 2 (4.0) 16 (32.0)
Indian 1 (2.0) 10 (20.0)
Mixed ethnicity 0 (0.0) 0 (0.0)
Other 0 (0.0) 1 (2.0)
Religion, n (%) <0.001*
No religion 6 (12.0) 0 (0.0)
Buddhism 31 (62.0) 6 (12.0)
Taoism 5 (10.0) 2 (4.0)
Christian 4 (8.0) 12 (24.0)
Muslim 3 (6.0) 20 (40.0)
Hindu 0 (0.0) 4 (8.0)
Other 1 (2.0) 6 (12.0)
Education level, n (%) <0.001*
Less than Primary 31 (62.0) 6 (12.0)
Greater than Primary and less than Secondary 3 (6.0) 0 (0.0)
Secondary 11 (22.0) 29 (58.0)
More than Secondary 5 (10.0) 15 (30.0)
House, n (%) 0.04*
Owner 39 (78.0) 47 (94.0)
Live on rent/Other 11 (10.0) 3 (2.0)
Heart Disease, n (%) 2 (4.0) 2 (4.0) 1.00
Diabetes, n (%) 6 (12.0) 12 (24.0) 0.19
Stroke, n (%) 3 (6.0) 1 (2.0) 0.62
*Statistically significant
aGroup difference at baseline using t-test for independent groups for continuous variables and Fisher’s exact test for categorical variables (e.g., ethnicity,
religion, etc.)
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to evaluate complex interventions or pragmatic trial.
Such efforts allow opportunities to modify the approach
to be evaluated in a full scale more resource intensive
trial. Our feasibility study was conducted from a per-
spective of introducing practical strategies in local pri-
mary care clinics with heavy caseloads. The high fidelity
of MC and telephone follow ups were key process out-
comes observed in our trial, and the positive feedback
from providers and hypertensive individuals indicates
that the existing polyclinic infrastructure and workflow
can be reconfigured, and the strategies institutionalized
for long term delivery of the proposed strategies in the
public health infrastructure in Singapore. At the same
time, only 50 % of physicians prescribed FDC to eligible
participants. Therefore, the full scale study design would
need additional measures to further enhance prescrip-
tion rates. A performance indicator such as a physician
management checklist embedded in the electronic health
Fig. 3 Intervention fidelity
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system indicating whether FDC was considered could be
an effective option. These strategies would be applicable
to many other countries where physicians and non-
physician health professionals work as a team for syner-
gistic benefit to achieve BP control, which remains a glo-
bal public health challenge.
Our feasibility results suggest a potentially favorable
effect of the packaged intervention on the healthy life-
style index which is consistent with reported literature
advocating physical activity, weight management and
healthy diet to optimize benefit of drug therapy on car-
diovascular risk [22]. Previous studies have shown that
GP practices offer an excellent avenue to address mul-
tiple risk factors including lifestyle modification [23].
Our study was designed to emphasize this important
aspect of hypertension management during various
points of contact with the individuals during and fol-
lowing the clinic visit. First, lifestyle advice was an inte-
gral part of physician treatment algorithm for all
hypertensive individuals. Second, all individuals at high
risk received MC by trained nurses. Use of MC is in-
creasingly effective in the management of chronic dis-
eases [24]. The MC curriculum used in our study was
especially developed using local case-based scenarios,
and focused on life style management and adherence to
medications. Third, all individuals received monthly
telephone follow-up during which a standardized
checklist on lifestyle and medication adherence was ad-
ministered by nurses trained in a MC, with counseling
offered as needed. This strategy was also relatively low
cost at S$ 4.5 for a monthly telephone call is an add-
itional strength, although formal cost effectiveness
needs to be evaluated in the full scale study. Finally,
fixed-dose antihypertensive regimens offered to high
risk individuals at a subsidized cost have been shown to
improve adherence, as opposed to multiple single medica-
tions [25]. Nevertheless, our feasibility trial suggests that a
packaged intervention using the unique combination of
Table 2 Change in outcome variables from baseline
Variables Intervention group Within-group
p-value




(n = 50) (n = 50)
Healthy Lifestyle Index, mean (SD)a
Baseline 2.1 (0.99) 2.4 (1.03)
Final 2.3 (1.04) 0.43 2.2 (0.89) 0.35
Change 0.16 (0.68) −0.18 (0.75) 0.02*
Healthy Lifestyle Index, median (IQR)a
Baseline 2 (1, 3) 2 (2, 3)
Final 2 (2, 3) 0.54 2 (2, 3) 0.48
Change 0 (0, 0) 0 (−1, 0) 0.01*
Anti-hypertensive medication adherence
PDC (any medication class)b,c, % 95.27 83.78 <0.01*
PDC (all medication classes)b,c, % 92.05 84.47 0.03*
Mean Systolic blood pressure
(> = 140 mmHg), mean (SD)
Baseline 158.0 (11.9) <0.001* 160.66 (15.7) <0.001*
Finald 142.79 (13.3) 140.17 (12.9)
Adjusted change mm Hg, mean (95%CI)e −17.58 (−24.06 to −11.11) −18.99 (−25.88 to −12.09) 0.58
Mean Diastolic blood pressure
(> = 90 mmHg), mean (SD)
Baseline 94.6 (5.7) <0.001* 96.86 (11.5) <0.001*
Finald 80.82 (11.7) 86.86 (10.5)
Adjusted change mm Hg, mean (95%CI)e −15.6 (−20.85 to −10.35) −12.93 (−18.48 to −7.37) 0.19
PDC proportion of days covered
*Statistically significant
aHealthy Lifestyle Index is a cumulative score of 5 variables; BMI, Physical activity, Dietary habit, Dietary quality and Smoking (Additional file 2)
bPDC = (Total number of days’ supply of medication dispensed/length of corresponding follow-up) x 100
Ref. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to
antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–1605
cAdjusted for age and gender
dMissing data was imputed by using the mean values of final
eAdjusted for age, gender, house ownership, diabetes and baseline values
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specified components is likely to improve the healthy life
style score as well as adherence to antihypertensive medi-
cations in individuals seeking care in the busy polyclinics
in Singapore.
The adjusted decline in systolic and diastolic BP within
the intervention and the usual care groups was marked,
however between-group differences were not significant.
This suggests the possibility of a Hawthorne effect with
BP regression to the mean in both groups at 3 months.
However, the benefits of improved lifestyle and adherence
to antihypertensive medications observed in the interven-
tion group would require longer term follow up in a larger
number of participants. An adequately powered study ac-
counting for clustering is needed to study the effectiveness
and cost effectiveness of the intervention on BP and other
clinically meaningful outcomes. Our study underscores
the need for a control group in these comparisons.
Finally, a limited participant satisfaction survey indi-
cated that both providers and participants appreciated
the utility of the strategies.
Our findings have limitations. The parallel groups
were allocated clusters, and differences in outcomes do
not account for clustered data.. However, the main aim
of the feasibility study was to conduct a pilot of stan-
dardized protocol incorporating the main components
of the intervention and using the polyclinic workforce
infrastructure which we were able to achieve with high
fidelity. Moreover, we were able to demonstrate accept-
ability of key intervention components in predomin-
antly older adults—the fastest growing segment of
Singapore population [26]. Thus, we believe a full scale
study of the proposed strategies is feasible in the poly-
clinics to conclusively answer questions of clinical and
cost effectiveness. The clues from our feasibility study on
the healthy lifestyle index in conjunction to adherence to
antihypertensive medications indicate success is likely for
both aims.Table 4 Quality assessment
Response Telephone follow-ups Motivational conversation
Target = 45; Achieved = 43
(95.5 %)
Target = 19; Achieved = 18
(94.7 %)
Very happy 12 7
Happy 25 9
Neutral 6 2
Table 5 Consumption and cost of antihypertensive medications
Measures Intervention
group (n = 42)
No Intervention
group (n = 49)
Antihypertensive medications
consumed per day (n)
1.7 1.4
Cost per week (SGD) 1.8 1.7
Table 3 Change in outcome variables from baseline
Intervention group Within-group
p-value




(n = 50) (n = 50)
EQ-5D-5 L, mean (SD)a,b
Baseline 0.94 (0.1) 0.91 (0.1)
Final 0.96 (0.1) 0.20 0.93 (0.1) 0.28
Adjusted change, mean (95%CI)c 0.01 (−0.04 to 0.06) −0.02 (−0.07 to 0.03) 0.19
Met-min/week, median (IQR)d,e
Baseline 713 (903.8) 0.09 1125 (1928.3) 0.72
Final 1253 (693) 1074 (1908.4)
Change, median (IQR) 0 (603.8) 53.25 (1062.4) 0.52
BMI, mean (SD)
Baseline 25.75 (4.0) 27.17 (4.6)
Finalf 25.64 (3.8) 0.04* 27.50 (4.8) 0.30
Adjusted change, mean (95%CI)g −1.06 (−2.11 to −0.01) −0.58 (−1.69 to 0.53) 0.23
BMI body mass index
*Statistically significant
aEQ-5D-5 L calculated on Japanese version
bMissing data was imputed by using the baseline values
cAdjusted for age, gender, house ownership, diabetes and baseline values
dMet-min/week = (Walk Mets x min x days) + (Mod Mets x min x days) + (Vig Mets x min x days)
eMissing data was imputed by using the median value of final
fMissing data was imputed by using the mean values of final
gAdjusted for age, gender, house ownership, diabetes and baseline values
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Conclusion
In conclusion, our study on 100 individuals with un-
controlled hypertension in two polyclinics in Singapore
resulted in high intervention fidelity and signaled im-
provement in healthy life style factors and adherence to
anti-hypertensive medications compared to usual care.
The packaged intervention needs to be evaluated per-
haps with additional measures to enhance FDC pre-
scription in a full scale trial for effectiveness and cost
effectiveness on BP lowering and improvement of car-
diovascular risk for future scalability and sustainability.
Our proposed trial has significant clinical practice and pub-
lic health policy implications in Singapore, and globally.
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